share_log

Cantor Fitzgerald Reiterates Neutral on TherapeuticsMD, Announces $1 Price Target

Cantor Fitzgerald Reiterates Neutral on TherapeuticsMD, Announces $1 Price Target

坎托·菲茨杰拉德重申对TherapeuticSMD持中立态度,宣布1美元的目标股价
Benzinga Real-time News ·  2022/07/13 08:20

Cantor Fitzgerald analyst Louise Chen reiterates TherapeuticsMD (NASDAQ:TXMD) with a Neutral and announces $1 price target.

坎托·菲茨杰拉德分析师路易丝·陈重申TherapeuticSMD(纳斯达克股票代码:TXMD)持中立态度,并宣布目标股价为1美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发